ondansetron ultra-low dose (AD04) - Adial
alhydrogel injectable (AD04) - ADvantage Therap
http://www.ncbi.nlm.nih.gov/pubmed/38706269
 
A Fernández Santana Iii; A Schneeberger; B Dubois; B Haaland; C H Mallinckrodt; J Harrison; M Morgan; O Peters; P O'Keefe; S Hendrix; S P Dickson
 
May 6, 2024
 
Next